What is Marker Therapeutics, Inc. Common Stock's Market Cap?

Marker Therapeutics, Inc. Common Stock's Market Cap is $16.0M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Enterprise Value?

Marker Therapeutics, Inc. Common Stock's Enterprise Value is $4.7M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Price / Sales?

Marker Therapeutics, Inc. Common Stock's Price / Sales is 4.5×, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's EV / Revenue?

Marker Therapeutics, Inc. Common Stock's EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Revenue (TTM)?

Marker Therapeutics, Inc. Common Stock's Revenue (TTM) is $3.5M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Net Income (TTM)?

Marker Therapeutics, Inc. Common Stock's Net Income (TTM) is -$8.7M, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.

What is Marker Therapeutics, Inc. Common Stock's Net Debt?

Marker Therapeutics, Inc. Common Stock's Net Debt is -$11.3M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Marker Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SKLLN7

0.96▼ 0.11 (-10.27%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA: —

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA: —
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 1.07
Day's Range: 0.96 – 1.12
52-Week Range: 0.84 – 2.46
Volume: 114.3K
Avg Volume: 136.8K

Share Statistics

Shares Outstanding
Employees: 5
Exchange: XNAS
Listed: 1998-01-07

Share count as of August 7, 2026

Marker Therapeutics, Inc. Common Stock (MRKR) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Marker Therapeutics, Inc. Common Stock (MRKR)

What is Marker Therapeutics, Inc. Common Stock's Market Cap?: Marker Therapeutics, Inc. Common Stock's Market Cap is $16.0M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Enterprise Value?: Marker Therapeutics, Inc. Common Stock's Enterprise Value is $4.7M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Price / Sales?: Marker Therapeutics, Inc. Common Stock's Price / Sales is 4.5×, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's EV / Revenue?: Marker Therapeutics, Inc. Common Stock's EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Revenue (TTM)?: Marker Therapeutics, Inc. Common Stock's Revenue (TTM) is $3.5M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Net Income (TTM)?: Marker Therapeutics, Inc. Common Stock's Net Income (TTM) is -$8.7M, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Marker Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.
What is Marker Therapeutics, Inc. Common Stock's Net Debt?: Marker Therapeutics, Inc. Common Stock's Net Debt is -$11.3M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · MRKRAs-filed SEC (XBRL) data